"A slate of experimental peptide therapies are under scrutiny today in what marks the beginning of a two-day meeting to help determine whether the compounds will become available from specialized pharmacies...None of them has undergone the kind of large-scale trials to establish safety and effectiveness that are required for FDA drug approvals."
https://www.npr.org/2026/07/23/nx-s1-5903202/fda-peptides-restrictions
#PublicHealth #FDA #HHS #peptides #pharmacies #wellness #MAHA